缓闭夹治疗非囊性椎基底动脉瘤:一项回顾性病例系列
本文回顾性分析10例非囊性椎基底动脉瘤患者采用实验性缓闭夹(SCC)治疗的临床与影像结局,平均随访6.7年,观察死亡率为20%,低于同期未破裂患者预期死亡率52.7%,6例存活且改良Rankin量表评分不变或改善,死亡与动脉瘤向后投射及晚期治疗相关。
要点
- 10例非囊性椎基底动脉瘤患者接受实验性缓闭夹治疗,平均随访6.7年,观察死亡率20%。
- 6例存活者改良Rankin量表评分不变或改善,4例于治疗后12个月内死亡。
- 死亡率与动脉瘤向后投射及晚期治疗相关,作者认为需更多研究完善该技术。
核心结论
- 在这一小型病例系列中,当治疗时机和动脉瘤解剖适合时,使用缓闭夹克服了非囊性椎基底动脉瘤的自然病史。
- 缓闭夹可能促进动脉瘤血栓形成和侧支再激活。
- 需要更多研究来更好地开发缓闭夹。
研究设计与样本
- 回顾性分析接受实验性缓闭夹治疗的非囊性椎基底动脉瘤患者的临床、影像和结局数据。
- 共纳入10例患者,其中男性7例,平均年龄49.5岁(范围18-73岁)。
主要发现
- 6例以占位效应症状就诊,1例缺血性卒中,2例蛛网膜下腔出血,1例脑积水。
- 5例接受血运重建加缓闭夹应用,5例仅用缓闭夹治疗,平均随访6.7年。
- 同期未破裂非囊性椎基底动脉瘤既往治疗方案的预期死亡率为52.7%,而观察到的死亡率为20%。
- 4例在治疗后12个月内死亡,死因为脑干缺血性卒中、低级别蛛网膜下腔出血、临床情况差和原因不明。
- 末次随访时6例存活,改良Rankin量表评分不变或改善;死亡率与动脉瘤向后投射及晚期治疗相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Vertebrobasilar artery nonsaccular aneurysms (VBANSAs) are associated with a 13% annual mortality. Revascularization and flow diversion are life-saving options in select cases; technical failures and rapid hemodynamic changes may contribute to unwanted outcomes. We describe a technique and report clinical outcomes of patients treated with an experimental slow-closing clip (SCC). METHODS: An experimental SCC was created to gradually close the parent artery of aneurysms. Clinical, radiographic, and outcome data from patients with VBANSAs who underwent experimental treatment with the SCC were retrospectively analyzed. RESULTS: Among 10 patients (7 men; mean age, 49.5 years; range, 18-73 years), 6 presented with mass effect symptoms, 1 with ischemic stroke, 2 with subarachnoid hemorrhage, and 1 with hydrocephalus. Five patients underwent revascularization plus SCC application, and 5 were treated with SCC alone. The mean follow-up was 6.7 years. The expected mortality among patients with unruptured VBANSAs with previous treatment options in this period was 52.7%, whereas the observed rate was 20%. Four patients died within 12 months after treatment. Causes of death were brainstem ischemic stroke, poor-grade subarachnoid hemorrhage, poor clinical presentation, and unknown. Six patients were alive at last follow-up, with unchanged or improved modified Rankin Scale scores. Mortality was associated with posterior-projecting aneurysms and late-stage treatment. CONCLUSIONS: In this small case series, use of SCC overcame the natural history of VBANSAs when treatment timing and aneurysm anatomy were suitable. The SCC potentially favors aneurysm thrombosis and collateral reactivation. More studies are necessary to better develop the SCC.
引用
- Rezai Jahromi B, Dashti R, Rustemi O, et al. Slow-Closing Clip for the Treatment of Nonsaccular Vertebrobasilar Aneurysms: A Retrospective Case Series. World Neurosurg. 2022. PMID: 36241141. doi:10.1016/j.wneu.2022.10.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。